Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
COCP on Nasdaq
Shares outstanding
13,831,528
Price per share
$0.98
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
664,982
Total reported value
$831,248
% of total 13F portfolios
0%
Share change
-21,534
Value change
-$40,108
Number of holders
21
Price from insider filings
$0.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FROST PHILLIP MD ET AL 18% +65% $3,078,992 +$1,349,571 2,462,012 +78% Phillip Frost, M.D. 28 Oct 2025

As of 30 Sep 2025, 21 institutional investors reported holding 664,982 shares of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP). This represents 4.8% of the company’s total 13,831,528 outstanding shares.

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 270,443 $453,344 +$324 $0.98 7
2025 Q3 664,982 $831,248 -$40,108 $1.25 21
2025 Q2 686,516 $1,022,928 -$87,903 $1.49 21
2025 Q1 748,773 $1,064,069 +$47,078 $1.42 23
2024 Q4 711,389 $1,437,038 -$15,989 $2.02 23
2024 Q3 719,274 $1,265,944 +$79,057 $1.76 19
2024 Q2 674,355 $1,571,278 -$90,505 $2.33 13
2024 Q1 721,322 $1,013,555 +$53,963 $1.40 14
2023 Q4 683,341 $1,173,672 -$35,542 $1.72 16
2023 Q3 704,225 $1,316,878 +$61,523 $1.87 15
2023 Q2 666,895 $1,594,259 -$144,985 $2.39 19
2023 Q1 738,638 $1,468,069 -$651,598 $1.99 19
2022 Q4 1,065,912 $2,076,645 +$2,076,610 $1.95 18